Increasing prostate cancer incidence rates highlight the importance of more timely diagnosis with the ultimate aim of reducing cancer-specific mortality, while maintaining patients quality of life. Until recently, digital rectal examination and prostate-specific antigen have been used for diagnosis of prostate cancer. Recent advances in medical technologies and laboratory testing have led to introducing new cancer markers into clinical practice. The most highly demanded of them are the PCA-3, -2proPSA and Prostate Health Index. Despite the wide range of laboratory tests, a prostate biopsy with a subsequent morphological examination of biopsy tissue specimens remains the only way to definitively diagnose prostate cancer.
Urologiia (Moscow, Russia : 1999). 2016 Dec [Epub]
A O Vasilyev, E A Prilepskaya, M V Kovylina, A V Govorov, A V Sadchenko, A V Sidorenkov, D Yu Pushkar
Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow.